Year: 2020

T4299SSTMicroelectronics et Schneider Electric dévoilent une solution avancée de comptage de personnes embarquant de l’intelligence artificielle sur STM32 L’intelligence artificielle permet de mieux comprendre le taux d’occupation des bâtimentsGenève (Suisse), le 17 novembre 2020 —STMicroelectronics (NYSE : STM), un leader mondial des semiconducteurs dont les clients couvrent toute la gamme des applications électroniques et Schneider Electric, leader de la transformation numérique de la gestion de l’énergie et des automatismes, démontrent un prototype de capteur IoT qui permet de déployer de nouveaux services de gestion des bâtiments et de réaliser des gains d’efficacité en optimisant la compréhension de leur niveau d’occupation et de leur utilisation.Les deux entreprises ont collaboré pour intégrer l’intelligence artificielle (IA) dans...

Paris, November, 17th 2020,On November 9th, Casino launched a tender offer to repurchase the outstanding bonds due in May 2021 (ISIN: FR0011052661), June 2022 (ISIN: FR0013260379), January 2023 (ISIN: FR0011400571) and March 2024 (ISIN: FR0011765825).Following the bond tender offer, settlement of which is expected to take place on November 20th, 2020, Casino will repurchase: (i) for the bonds due in May 2021, an aggregate principal amount of € 194,100,000, (ii) for the bonds due in June 2022, an aggregate principal amount of € 8,500,000,         (iii) for the bonds due in January 2023, an aggregate principal amount of € 11,500,000 and (iv) for the bonds due in March 2024, an aggregate principal amount of € 7,800,000. The bond tender offer will amount to € 221,900,000.Following this transaction, the cumulative amount of bond repurchases...

Paris, le 17 novembre 2020,Casino a lancé le 9 novembre une offre de rachat portant sur les obligations à échéances mai 2021 (ISIN: FR0011052661), juin 2022 (ISIN : FR0013260379), janvier 2023 (ISIN : FR0011400571) et mars 2024 (ISIN : FR0011765825) en circulation.À l’issue de l’offre de rachat, dont le règlement est prévu le 20 novembre 2020, Casino rachètera :           (i) pour les obligations à échéance mai 2021, un montant nominal de 194 100 000 euros, (ii) pour les obligations à échéance juin 2022, un montant nominal de 8 500 000 euros, (iii) pour les obligations à échéance janvier 2023, un montant nominal de 11 500 000 euros et (iv) pour les obligations à échéance mars 2024, un montant nominal de 7 800 000 euros, portant le montant total de l’offre de rachat à 221 900 000 euros.Cette opération porte le montant cumulé des rachats...

ROCKVILLE, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced a collaboration with The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) led by Eva Morava-Kozicz, M.D. Ph.D., Principal Investigator of the trial, Professor of Medical Genetics, Senior Associate Consultant, Department of Clinical Genomics, Mayo Clinic and Editor in Chief of the Journal of Inherited Metabolic Disease on a prospective pivotal trial evaluating the safety and efficacy of CERC-801 in patients suffering from Phosphoglucomutase-1 deficiency related congenital disorders of glycosylation (PGM1-CDG).Dr. H. Jeffrey Wilkins, M.D., Chief Medical Officer for Cerecor, stated,...

BOSTON, Nov. 17, 2020 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced the appointment of Lynette Hopkinson as Senior Vice President of Regulatory. Ms. Hopkinson joins Imara with 25 years of experience in the pharmaceutical and biotech industries, where she led global regulatory teams in strategy for multiple clinical development candidates and marketed products.“We are delighted to welcome Lyn to Imara; her expertise and understanding of global regulatory strategy and commercial affairs will be important as we continue to advance IMR-687 across multiple indications globally,” said Rahul Ballal, Ph.D., President and Chief Executive...

CRESSKILL, N.J. and JERUSALEM, Nov. 17, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced, non-invasive treatment of brain disorders, today announced that it will host a key opinion leader (KOL) call on Deep Transcranial Magnetic Stimulation (Deep TMS) for treating psychiatric disorders on Monday, November 23, 2020, at 10:00 AM Eastern Time.The event will feature a presentation by KOL Owen Muir, M.D., a psychiatrist at Brooklyn Minds, who will discuss the current treatment landscape and the unmet medical need in treating patients with psychiatric diseases, such as major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). Dr. Muir will be available to answer questions at the conclusion of the call.BrainsWay’s management team will...

HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company’s continued execution of expanding and protecting its Intellectual Property (IP) portfolio. The Company now has 40 issued/allowed patents and 23 patent applications pending worldwide.“As we continue to make progress on the development, clinical and regulatory fronts, it is encouraging that we are also achieving our goals to broaden the protection of our novel technologies,” commented Harel Gadot, CEO, President and Chairman. “Strengthening our IP portfolio is a critical component of Microbot’s strategy for facilitating product evolution and maximizing future commercial opportunities.”The U.S. Patent and Trademark Office (USPTO) issued a Notice of...

VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, NASDAQ: KOR) announces it has received additional results from its new Lynnda Strip discovery east and west of the previously announced discovery hole ML20-168 (NR20-17: 106.7m @ 0.71g/t gold & 48.8m @ 0.90 g/t gold). The new oxide, vein intersections are within broad zones of lower-grade disseminated mineralization highlighted by an Upper Zone vein in hole ML20-170 (42.7m @ 2.06 g/t gold including 12.2m @ 4.88 g/t gold) and a Lower Zone vein in hole ML20-166 (33.5m @ 1.63 g/t gold including 7.6m @ 3.96 g/t gold). These thick zones of mineralization continue to display a gold system thickness of 150-200 metres that all end in mineralization indicating additional potential at depth (Figure 1 & Table...

Assays received for 36 exploration drill holes from satellite targets (Clouds, Twin Hills West and Barking Dog) at Twin Hills.These targets are brownfields targets along trend and within a 2500m radius from Twin Hills Central.Significant new gold discoveries made at Clouds West and East, respectively 500m and 1500m east along strike from Twin Hills Central. Gold mineralization intersected includes:27m @ 1.22g/t (OKD059: 143 – 170), incl. 16m @ 1.74g/t (Clouds West)76m @ 0.75g/t (OKD093: 66 – 142m) incl. 37m @ 0.97g/t (Clouds East)22m @ 1.19g/t (OKD096: 120 – 142m) incl. 9m @ 2.44g/t (Clouds East)Both Clouds East and West lie along a prominent, high-intensity IP anomaly along strike from Twin Hills Central, therefore potentially doubling the Twin Hills Central mineralized strike length from 1500 to over 3000m in length.Rapid step-out drill...

VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — Search Minerals Inc. (TSXV: SMY) (“Search” or the “Company”), is pleased to announce that the Company is conducting a non-brokered private placement of up to 8,500,000 units (the “Units”) at a price of $0.06 per Unit for maximum gross proceeds of up to $510,000 (the “Offering”). Each Unit will be comprised of one common share and one share purchase warrant (a “Warrant”), with each Warrant entitling the holder to acquire an additional Share for a period of 2 years at a price of $0.06 in the first year and $0.08 in the second year.The Offering is expected to close on or about December 18, 2020 and is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the approval of the TSX Venture Exchange. All securities...